| US 7,482,020 B2 | ||
| Process for making an adjuvanted vaccine comprising host albumin | ||
| Kristina J. Hennessy, Bayer Corporation, 100 Bayer Rd., Pittsburgh, Pa. 15205-9741 (US); Karen K. Brown, Bayer Corporation, 100 Bayer Rd., Pittsburgh, Pa. 15205-9741 (US); Jennifer K. Lane, Bayer Corporation, 100 Bayer Rd., Pittsburgh, Pa. 15205-9741 (US); and Sandra L. Trump, Bayer Corporation , 100 Bayer Rd., Pittsburgh, Pa. 15205-9741 (US) | ||
| Filed on Sep. 02, 2003, as Appl. No. 10/654,534. | ||
| Application 10/654534 is a division of application No. 10/099182, filed on Mar. 14, 2002, granted, now 6,682,746. | ||
| Application 10/099182 is a division of application No. 10/015986, filed on Dec. 12, 2001, abandoned. | ||
| Application 10/015986 is a division of application No. 09/151219, filed on Sep. 10, 1998, abandoned. | ||
| Application 09/151219 is a division of application No. 08/531820, filed on Sep. 21, 1995, abandoned. | ||
| Prior Publication US 2005/0232948 A1, Oct. 20, 2005 | ||
| Int. Cl. A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 9/50 (2006.01); A61K 45/00 (2006.01); A61K 47/00 (2006.01); A61K 33/08 (2006.01); A01N 59/06 (2006.01) | ||
| U.S. Cl. 424—400 [424/499; 424/450; 424/278.1; 424/690; 424/689] | 1 Claim |
| 1. A process for making a vaccine for an animal species, wherein:
the vaccine comprises an antigen, an adjuvant, and serum or albumin;
and the process comprises:
mixing the serum or albumin with the antigen to form a mixture of antigen and serum or albumin,
lyophilizing the mixture of antigen and serum or albumin, and
mixing the adjuvant with the mixture of antigen and serum or albumin, wherein said serum or albumin comprises serum or albumin
obtained from said animal species.
|